Literature DB >> 24075798

Association between ultraviolet radiation, skin sun sensitivity and risk of pancreatic cancer.

Bich Tran1, David C Whiteman, Penelope M Webb, Lin Fritschi, Jonathan Fawcett, Harvey A Risch, Robyn Lucas, Nirmala Pandeya, Annaka Schulte, Rachel E Neale.   

Abstract

BACKGROUND: Ecological studies showing an inverse association between pancreatic cancer incidence and mortality and levels of ultraviolet radiation (UVR), suggest that higher levels of sun exposure may reduce risks of pancreatic cancer but there has been only one individual-level study that examined this issue. We aimed to examine the association between pancreatic cancer and markers of exposure to solar UVR, namely skin type, treatment of skin lesions, ambient UVR and time outdoors on work days.
METHODS: We used data from an Australian case-control study. Location at birth, residential location during adulthood, outdoors work, history of skin lesion treatment and sensitivity of the skin to the sun were obtained by questionnaire. We limited the analyses to Caucasians who answered the questionnaire about UVR (controls=589/711 recruited; cases=496/705 recruited). We used NASA's Total Ozone Mapping Spectrometer to estimate ambient UVR.
RESULTS: Being born in or living in areas of higher ambient UVR (compared to lower ambient UVR) was associated with about 30-40% lower risk of pancreatic cancer. People with fair skin colour had 47% lower risk of pancreatic cancer than those with dark skin colour (95% CI 0.37-0.75). There was some suggestion of increased risk with increased average number of hours spent outside at work.
CONCLUSIONS: This study suggests that people with light skin colour or those born or living in areas of high ambient UVR have lower risk of pancreatic cancer. Our analysis supports an association between UVR and pancreatic cancer, possibly mediated through production of vitamin D.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  25(OH)D; 25-hydroxyvitamin D; CI; History of skin cancer; OR; Pancreatic cancer; Skin colour; Skin type; UVR; Ultraviolet radiation; confidence interval; odds ratio; ultraviolet radiation

Mesh:

Year:  2013        PMID: 24075798     DOI: 10.1016/j.canep.2013.08.013

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  12 in total

1.  Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium.

Authors:  M Waterhouse; H A Risch; C Bosetti; K E Anderson; G M Petersen; W R Bamlet; M Cotterchio; S P Cleary; T I Ibiebele; C La Vecchia; H G Skinner; L Strayer; P M Bracci; P Maisonneuve; H B Bueno-de-Mesquita; W Zaton Ski; L Lu; H Yu; K Janik-Koncewicz; J Polesel; D Serraino; R E Neale
Journal:  Ann Oncol       Date:  2015-05-14       Impact factor: 32.976

2.  Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study.

Authors:  Vanessa L Beesley; Leesa F Wockner; Peter O'Rourke; Monika Janda; David Goldstein; Helen Gooden; Neil D Merrett; Dianne L O'Connell; Ingrid J Rowlands; David K Wyld; Rachel E Neale
Journal:  Support Care Cancer       Date:  2016-04-16       Impact factor: 3.603

3.  Dietary acrylamide and the risk of pancreatic cancer in the International Pancreatic Cancer Case-Control Consortium (PanC4).

Authors:  C Pelucchi; V Rosato; P M Bracci; D Li; R E Neale; E Lucenteforte; D Serraino; K E Anderson; E Fontham; E A Holly; M M Hassan; J Polesel; C Bosetti; L Strayer; J Su; P Boffetta; E J Duell; C La Vecchia
Journal:  Ann Oncol       Date:  2017-02-01       Impact factor: 32.976

4.  A novel gemcitabine derivative-loaded liposome with great pancreas-targeting ability.

Authors:  Pei-Wen Li; Shi Luo; Lin-Yu Xiao; Bo-le Tian; Li Wang; Zhi-Rong Zhang; Ying-Chun Zeng
Journal:  Acta Pharmacol Sin       Date:  2019-04-23       Impact factor: 6.150

5.  Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium.

Authors:  C Bosetti; V Rosato; D Li; D Silverman; G M Petersen; P M Bracci; R E Neale; J Muscat; K Anderson; S Gallinger; S H Olson; A B Miller; H Bas Bueno-de-Mesquita; G Scelo; V Janout; I Holcatova; P Lagiou; D Serraino; E Lucenteforte; E Fabianova; P A Baghurst; W Zatonski; L Foretova; E Fontham; W R Bamlet; E A Holly; E Negri; M Hassan; A Prizment; M Cotterchio; S Cleary; R C Kurtz; P Maisonneuve; D Trichopoulos; J Polesel; E J Duell; P Boffetta; C La Vecchia; P Ghadirian
Journal:  Ann Oncol       Date:  2014-07-23       Impact factor: 32.976

6.  XRCC1 Arg194Trp and Arg399Gln polymorphisms and risk of extrahepatic cholangiocarcinoma: a hospital-based case-control study in China.

Authors:  Yuanfeng Gong; Ming Qi; Jun Chen; Runya Fang; Cong Mai; Tiejun Chen; Hui Tang; Yunqiang Tang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

7.  Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.

Authors:  Erica J Childs; Evelina Mocci; Daniele Campa; Paige M Bracci; Steven Gallinger; Michael Goggins; Donghui Li; Rachel E Neale; Sara H Olson; Ghislaine Scelo; Laufey T Amundadottir; William R Bamlet; Maarten F Bijlsma; Amanda Blackford; Michael Borges; Paul Brennan; Hermann Brenner; H Bas Bueno-de-Mesquita; Federico Canzian; Gabriele Capurso; Giulia M Cavestro; Kari G Chaffee; Stephen J Chanock; Sean P Cleary; Michelle Cotterchio; Lenka Foretova; Charles Fuchs; Niccola Funel; Maria Gazouli; Manal Hassan; Joseph M Herman; Ivana Holcatova; Elizabeth A Holly; Robert N Hoover; Rayjean J Hung; Vladimir Janout; Timothy J Key; Juozas Kupcinskas; Robert C Kurtz; Stefano Landi; Lingeng Lu; Ewa Malecka-Panas; Andrea Mambrini; Beatrice Mohelnikova-Duchonova; John P Neoptolemos; Ann L Oberg; Irene Orlow; Claudio Pasquali; Raffaele Pezzilli; Cosmeri Rizzato; Amethyst Saldia; Aldo Scarpa; Rachael Z Stolzenberg-Solomon; Oliver Strobel; Francesca Tavano; Yogesh K Vashist; Pavel Vodicka; Brian M Wolpin; Herbert Yu; Gloria M Petersen; Harvey A Risch; Alison P Klein
Journal:  Nat Genet       Date:  2015-06-22       Impact factor: 38.330

8.  Retrospective analysis of the influence of 25-hydroxyvitamin D on disease progression and survival in pancreatic cancer.

Authors:  Erica M McGovern; Mark E Lewis; Michelle L Niesley; Nhu Huynh; Jeffrey B Hoag
Journal:  Nutr J       Date:  2016-02-12       Impact factor: 3.271

Review 9.  The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2016-01-08

10.  Development of Octyl Methoxy Cinnamates (OMC)/Silicon Dioxide (SiO₂) Nanoparticles by Sol-Gel Emulsion Method.

Authors:  Pey-Shiuan Wu; Yi-Ching Lee; Yi-Ching Kuo; Chih-Chien Lin
Journal:  Nanomaterials (Basel)       Date:  2017-12-07       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.